London-based Engitix secures a €21M funding extension to accelerate its extracellular matrix–targeted therapies for cancer and fibrosis, strengthening its position in drug discovery.
Author: Elyse Christian
Norwegian incubator OSE scores a second major biotech exit as Amgen acquires oncology startup Dark Blue in a deal worth up to $840M.
Icelandic biotech Alvotech ramps up biosimilars development and manufacturing capacity to meet surging global demand for affordable biologic medicines.
Clean energy could require five times more critical metals by 2040. New mining, recycling, and processing technologies may prevent shortages and price shocks.
Planet A says space infrastructure is the century’s most underpriced opportunity, pointing to launch, satellites, and in-orbit services as the next backbone for the global economy.
German BioTech startup BIOWEG has raised €1.5 million to turn industrial waste streams into valuable metals, targeting cleaner recovery methods and circular manufacturing.
Rochester’s homebuying experience stands out for its neighborhoods, pricing, and community feel. Here’s why buyers say Rochester feels different—and what to know before you bid.
Joanna Lumley is back on screen with a new globe-trotting series for the BBC, taking viewers along one of the continent’s most storied waterways in Joanna Lumley’s Danube: Europe’s Mightiest River
Frankincense demand is surging, but Boswellia trees in Somaliland and beyond are being over-tapped, hit by pests and climate stress—threatening a centuries-old trade.
Edison, a FutureHouse spinout, has raised $70M to develop autonomous AI scientists for biology and chemistry—aiming to speed discovery from hypothesis to lab-ready results.